CD40LG and Guillain-Barre syndrome: A case-control study performed in French-Polynesia supported the direct connection between ZIKV infection and GBS development as almost all patients (41 of 42) with GBS had detectable anti-ZIKV IgM/IgG levels and all showed neutralizing antibodies against ZIKV (40).